AzTrials
AzTrials

Shoulder PainNCT06186180

Inspiratory Muscle Training on Diaphragm Thickness, Inspiratory Muscle Strength and Shoulder Pain in Tennis Player

A study testing inspiratory muscle training in people with Shoulder Pain and Inspiratory Muscle Training, run by Universidad Francisco de Vitoria at 2 sites in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Shoulder pain is one of the most common musculoskeletal conditions among athletes and sports enthusiasts who engage in overhead sports, and it can be highly disabling. Since the shoulder is one of the joints with the greatest range of motion in the human body, it is important to seek strategies that address trunk… Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Shoulder Pain, Inspiratory Muscle Training
What is being tested?
inspiratory muscle training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesSpain
Study dates
1 Nov 2025to 15 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • tennis player who suffered from inespecific shoulder pain
  • training at least two times per week
  • Have experienced at least 1 episode of non-specific shoulder pain in the last month
  • A positive result on diagnostic tests performed: Neer Test and Jobe Test

Who cannot join

  • Having taken anti-inflammatories or muscle relaxants within the last 72 hours before the study
  • pregnancy
  • Previous diagnosis of respiratory or neurological diseases
  • Previous surgeries, fractures, and dislocations in the dominant shoulder
  • Inability to follow instructions during the study
  • All those for whom measuring maximum inspiratory pressure is contraindicated: unstable angina, recent myocardial infarction (within 4 weeks of the event) or myocarditis, uncontrolled systemic hypertension, recent pneumothorax, post-lung biopsy surgery of less than one week, postoperative abdominal or genitourinary surgery of less than 6 months, and urinary incontinence

Trial locations and contacts

2 sites in 1 country.

Spain2 sites
  • Davinia Vicente-Campos

    Pozuelo de Alarcón, Madrid, 28223

  • Universidad Francisco de Vitoria

    Pozuelo de Alarcón, Madrid, 28223

Other trials in Spain

About this study

Official title: Effects of Inspiratory Muscle Training on Diaphragm Thickness, Inspiratory Muscle Strength and Non-especific Shoulder Pain in Federated Tennis Player

Shoulder pain is one of the most common musculoskeletal conditions among athletes and sports enthusiasts who engage in overhead sports, and it can be highly disabling. Since the shoulder is one of the joints with the greatest range of motion in the human body, it is important to seek strategies that address trunk stability comprehensively to achieve full and effective joint mobility. The central role of the diaphragm in trunk stabilization has been the subject of research for over 50 years, although the exact mechanisms are still not fully understood.

The objective of this study is to assess the effects of inspiratory muscle training on diaphragm thickness, inspiratory muscle strength, and shoulder pain in adult tennis players with non-specific shoulder pain.

This is a single-blind, randomized controlled clinical trial. The intervention will last for 8 weeks. Patients with non-specific shoulder pain will be randomly assigned to one of two groups. The experimental group will undergo specific inspiratory muscle training, while the control group will receive no specific training intervention. Measurements of diaphragm thickness, inspiratory muscle strength, and shoulder pain will be taken before and after the intervention.

Being tested
inspiratory muscle training
Medical subject headings
Shoulder Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • inspiratory muscle trainingOther

    They will perform 5 sets of 10 repetitions with a 1-minute rest between sets, 5 days a week, using a specific respiratory muscle training device

Study groups in NCT06186180
Study groupRoleWhat they receive
inspiratory muscle trainingExperimentalThey will perform 5 sets of 10 repetitions with a 1-minute rest between sets, 5 days a week, using a specific respiratory muscle training device.
Receives: Other: inspiratory muscle training
controlNo interventionno intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. diaphragm thickness

    The thickness of the diaphragm will be measured using ultrasound, with a Toshiba Xario 100 ultrasound machine. Image acquisition will be performed by a physiotherapist experienced in musculoskeletal ultrasound. A linear probe (Toshiba PLT-805AT) with a frequency range of 8 to 12 MHz and a 54 mm probe footprint will be used to perform transcostal measurements at rest and in the supine position, using the B-Mode of ultrasound imaging (preset at 3 cm depth, 12MHz frequency, 64 gain points, 64 dynamic range points, and a single focus point located at 2 cm depth). Bilateral transcostal images will be obtained with the linear probe placed perpendicular to the last intercostal space, allowing for adequate visualization of the diaphragm without invasion of lung tissue during normal breathing

    Measured: before and after the 8 weeks of inspiratory muscle training

Secondary outcomes (5)
  1. maximal inspiratory pressure

    Inspiratory muscle strength will be measured using a portable device, POWERbreathe KH1. It is a simple test in which the subject performs a maximal forced inspiration against an airway occlusion mechanism in the mouth after a slow and prolonged near-residual volume expiration, yielding the maximum inspiratory pressure (MIP) value. The evaluation will be conducted with the subject seated in a chair (knees and hips at 90º), and their nose will be occluded with a clip. The advantage of this test is that it provides a quick and non-invasive way to assess inspiratory muscle strength through maximum inspiratory pressure. Three measurements will be taken, with 1 minute of rest between each measurement, and the best of the three will be selected, provided that there is no more than a 10% difference between them

    Measured: before and after the 8 weeks of inspiratory muscle training

  2. shoulder pain through VAS

    Shoulder pain will be measured using the Visual Analog Scale for Pain (VAS), which is a valid and reliable measure for assessing pain. Its validity has been demonstrated with high correlations to other pain measures (r=0.62 to 0.91), and it has good test-retest reliability (r=0.94 to 0.71)(31). Participants will indicate their maximum pain sensation during the past week using a 100-mm VAS, where 0 represents 'no pain' and 100 represents 'extreme and unbearable pain

    Measured: before and after the 8 weeks of inspiratory muscle training

  3. Upper trapezius, levator scapulae, middle deltoid and infraspinatus pain pressure threshold

    the measurement of pressure pain using an algometer will be performed at the upper trapezius, the levator scapulae, the middle deltoid, and the infraspinatus muscle as shown by studies at the shoulder level. The contact area will be 10mm, and it will be applied at a rate of 30 kPa/s. Patients will be instructed to signal the moment they feel the first sensation of pain

    Measured: before and after the 8 weeks of inspiratory muscle training

  4. The Shortened Disabilities of the Arm, Shoulder, and Hand Questionnaire (QuickDASH) - Activities of daily living score

    The Shortened Disabilities of the Arm, Shoulder, and Hand Questionnaire (QuickDASH) consists of 11 questions that assess daily activities, symptoms, social function, work function, sleep, and confidence. There are 5 points, with 1 indicating no difficulty and 5 indicating impossibility. The score is converted to a 100-point scale, with 100 representing the highest level of disability

    Measured: before and after the 8 weeks of inspiratory muscle training

  5. The Shortened Disabilities of the Arm, Shoulder, and Hand Questionnaire (QuickDASH) - Sports Module Score

    The QuickDASH Sports Module score will be used to assess the impact of arm, shoulder, or hand symptoms on the partipiants ability to perfom sport-related activites. This optional module includes 4 items focused on difficulty performing the selected sport or physical activity during the previous week. Each items is scored on a 5-point linkert scale. The final score is transformed to a 0-100 scale, where 0 indicates no disability and 100 indicates the graetest disability. All 4 items must be completed to calculate the module score.

    Measured: before and after the 8 weeks of inspiratory muscle training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2023
  2. Study start1 Nov 2025
  3. Primary completion15 Feb 2026
  4. Study completion15 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
Single blinded randomized clinical trial
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06186180
Sponsor's protocol ID
46/2022
Status last verified
May 2026
First submitted
8 Dec 2023
Last updated
8 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing inspiratory muscle training in people with Shoulder Pain and Inspiratory Muscle Training, run by Universidad Francisco de Vitoria at 2 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

diaphragm thickness (time frame: before and after the 8 weeks of inspiratory muscle training). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in